Cargando…

BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors

BACKGROUND: As major regulators of normal chondrogenesis, the bone morphogenic protein (BMP) and transforming growth factor β (TGFB) signaling pathways may be involved in the development and progression of central chondrosarcoma. In order to uncover their possible implication, the aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boeuf, Stephane, Bovée, Judith VMG, Lehner, Burkhard, van den Akker, Brendy, van Ruler, Maayke, Cleton-Jansen, Anne-Marie, Richter, Wiltrud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495847/ https://www.ncbi.nlm.nih.gov/pubmed/23088614 http://dx.doi.org/10.1186/1471-2407-12-488

Ejemplares similares

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
por: van Oosterwijk, Jolieke G, et al.
Publicado: (2012)

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
por: Peterse, Elisabeth F. P., et al.
Publicado: (2018)

A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
por: de Jong, Yvonne, et al.
Publicado: (2019)

Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013
por: van Maldegem, Annemiek M, et al.
Publicado: (2014)

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)

Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma
por: Palubeckaitė, Ieva, et al.
Publicado: (2020)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

Role of soluble endoglin in BMP9 signaling
por: Lawera, Aleksandra, et al.
Publicado: (2019)

Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst
por: Ong, Sheena L.M., et al.
Publicado: (2021)

The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo
por: Suijker, Johnny, et al.
Publicado: (2015)

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
por: van Oosterwijk, J G, et al.
Publicado: (2013)

Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts
por: Nelson, Elizabeth F., et al.
Publicado: (2012)

Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1
por: Saito, Takako, et al.
Publicado: (2017)

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
por: Addie, Ruben D., et al.
Publicado: (2019)

Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
por: Nolan-Stevaux, Olivier, et al.
Publicado: (2012)

Targeting survivin as a potential new treatment for chondrosarcoma of bone
por: de Jong, Y, et al.
Publicado: (2016)

Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression
por: Franceschini, Natasja, et al.
Publicado: (2021)

Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines
por: Suijker, Johnny, et al.
Publicado: (2015)

BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice
por: Bakker, Wineke, et al.
Publicado: (2021)

No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
por: Peterse, Elisabeth F. P., et al.
Publicado: (2016)

Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors
por: Boeuf, Stephane, et al.
Publicado: (2010)

Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014)

Endoglin integrates BMP and Wnt signalling to induce haematopoiesis through JDP2
por: Baik, June, et al.
Publicado: (2016)

Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4
por: Gallardo-Vara, Eunate, et al.
Publicado: (2020)

Selective blockade of TGFbeta in the mice model of collagen-induced arthritis
por: Gonzalo, Elena, et al.
Publicado: (2011)

TGFbeta and miRNA regulation in familial and sporadic breast cancer
por: Danza, Katia, et al.
Publicado: (2017)

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
por: Venneker, Sanne, et al.
Publicado: (2019)

Blockade of the interaction between BMP9 and endoglin on erythroid progenitors promotes erythropoiesis in mice
por: Yamaguchi, Ayami, et al.
Publicado: (2021)

IDH Mutations in Chondrosarcoma: Case Closed or Not?
por: Venneker, Sanne, et al.
Publicado: (2023)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
por: Huang, Qian, et al.
Publicado: (2022)

Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes
por: de Jong, Yvonne, et al.
Publicado: (2019)

Multiple osteochondromas
por: Bovée, Judith VMG
Publicado: (2008)

High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells
por: Andersson-Rusch, Clara, et al.
Publicado: (2023)

Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis
por: Owen, Nicola E., et al.
Publicado: (2020)

IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas
por: Cleven, Arjen H. G., et al.
Publicado: (2017)

Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy
por: de Graaff, Marieke A, et al.
Publicado: (2016)

Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway
por: French, Deborah, et al.
Publicado: (2013)

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
por: Kuijjer, Marieke L, et al.
Publicado: (2013)

TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure
por: De Santis Puzzonia, Marco, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0gska3gc58es0qr3odirqo8cct